Document is current
Any future updates will be listed below
-
Authors
Zhou, Xin https://orcid.org/0000-0001-8089-4507
Chen, Xin https://orcid.org/0000-0002-5310-5426
Davis, Mark M. https://orcid.org/0000-0001-6868-657X
Snyder, Michael P. https://orcid.org/0000-0003-0784-7987
-
Funding
Funding for this research was provided by:
Howard Hughes Medical Institute (Howard Hughes Medical Institute)
National Institute on Aging (P30AG059307)
Leona M. and Harry B. Helmsley Charitable Trust (Leona M. and Harry B. Helmsley Charitable Trust)
National Institutes of Health (U19AI057229)
- License Information
-
More Information
Article History
Received: 13 April 2024
Revised: 2 September 2024
Accepted: 4 September 2024
First Online: 19 February 2025
Declarations
:
: Not applicable.
: Not applicable.
: M.P.S. is a co-founder and the scientific advisory board member of Personalis, Qbio, January, SensOmics, Filtricine, Akna, Protos, Mirvie, NiMo, Onza, Oralome, Marble Therapeutics, and Iollo. He is also on the scientific advisory board of Danaher, Genapsys, and Jupiter. X.Z., X.C., M.M.D., and M.P.S. is an inventor on a relevant patent application (PCT/US2024/033663) titled "Systems and Methods for Assessment of Microbiome and Treatments Thereof". The patent is assigned to The Board of Trustees of the Leland Stanford Junior University.
